Skip to main content

Berkshire Hathaway Subsidiary Becomes Mitsui’s Largest Shareholder

Tipranks - Tipranks - Fri Oct 10, 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest announcement is out from Mitsui & Co ( (JP:8031) ).

Mitsui & Co., Ltd. announced that National Indemnity Company, a subsidiary of Berkshire Hathaway Inc., has become its largest shareholder, holding 10.12% of voting rights as of September 30, 2025. This change in shareholder structure may impact Mitsui’s strategic decisions and influence its market positioning, although the company has not verified the exact number of shares and has not provided specific future outlooks.

The most recent analyst rating on (JP:8031) stock is a Hold with a Yen3350.00 price target. To see the full list of analyst forecasts on Mitsui & Co stock, see the JP:8031 Stock Forecast page.

More about Mitsui & Co

Mitsui & Co., Ltd. is a diversified trading company based in Tokyo, Japan. It operates across various industries, including machinery, chemicals, energy, and food, with a focus on global market expansion and investment.

Average Trading Volume: 5,926,160

Technical Sentiment Signal: Buy

Current Market Cap: Yen10549.9B

Learn more about 8031 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Trending Articles

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).